GlaxoSmithKline Pharmaceuticals Limited PEG Ratio

GlaxoSmithKline Pharmaceuticals Limited's peg ratio stands at 256.76. That is above the sector sector average of 10.05. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

GlaxoSmithKline Pharmaceuticals Limited sits higher the its sector benchmark (10.05) with a PEG ratio of 256.76. That is roughly 2453.6% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Whether 256.76 is attractive depends on GlaxoSmithKline Pharmaceuticals Limited's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.

The history chart shows how GlaxoSmithKline Pharmaceuticals Limited's PEG ratio evolved across reporting periods, while the comparison chart places GLAXO.BO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.